|
|
|
|
|||||
|
|
|
TEANECK, N.J., Oct. 29, 2025 /PRNewswire/ -- Cognizant (Nasdaq: CTSH), one of the world's leading professional services companies, today announced its third quarter 2025 financial results.
"Third quarter revenue grew 6.5% year-over-year and 2.8% sequentially in constant currency, representing our fifth consecutive quarter of year-over-year organic revenue growth and our strongest sequential organic growth since 2022," said Ravi Kumar S, CEO. "We maintained our large deal momentum, signing six large deals in the quarter, bringing our year-to-date total to 16 with 40% growth in large deal TCV year-to-date compared to the same period last year. I am proud of our year-to-date top-tier revenue growth, which is a testament to our differentiated capabilities at the intersection of technology and industry. We believe our three vector AI builder strategy is gaining traction and we expect our early investments in AI-led platforms and IP on the edge will help power growth in the years ahead."
|
$ in millions, except per share data |
Q3 2025 |
|
Q3 2024 |
|
YTD Q3 2025 |
|
YTD Q3 2024 |
|
Revenue |
$5,415 |
|
$5,044 |
|
$15,775 |
|
$14,654 |
|
Y/Y Change |
7.4 % |
|
3.0 % |
|
7.6 % |
|
0.4 % |
|
Y/Y Change CC1 |
6.5 % |
|
2.7 % |
|
7.3 % |
|
0.3 % |
|
GAAP Operating Margin |
16.0 % |
|
14.6 % |
|
16.1 % |
|
14.6 % |
|
Adjusted Operating Margin1 |
16.0 % |
|
15.3 % |
|
15.7 % |
|
15.2 % |
|
GAAP Diluted EPS |
$0.56 |
|
$1.17 |
|
$3.22 |
|
$3.41 |
|
Adjusted Diluted EPS1 |
$1.39 |
|
$1.25 |
|
$3.93 |
|
$3.55 |
|
Our recently completed acquisitions contributed approximately 250 basis points to year-over-year revenue growth and approximately 350 basis points to the year-to-date revenue growth for Q3 2025 and YTD Q3 2025 periods, respectively. GAAP Diluted EPS includes a one-time non-cash income tax charge that negatively impacted Q3 2025 by $0.80 and YTD Q3 2025 by $0.79. |
"Third quarter revenue was well above our guidance range with broad-based growth across segments and geographies, including noteworthy performance in North America. Strong execution and cost discipline drove 70 basis points of year-over-year Adjusted Operating margin expansion, robust cash flow and year-to-date Adjusted EPS growth of 11%," said Jatin Dalal, CFO. "We have increased our full-year revenue guidance to 6.0% to 6.3% year-over-year constant currency growth, above our prior range and deployed $1 billion through share repurchases through Q3, underscoring our confidence in our growth strategy."
Bookings
On a trailing-twelve-month basis, bookings increased 5% year-over-year to $27.5 billion, which represented a book-to-bill of approximately 1.3x. Bookings in the third quarter declined 5% year-over-year. Third quarter bookings included six large deals, which are deals with total contract value of $100 million or greater.
Employee Metrics
On a trailing-twelve months basis, Voluntary Attrition - Tech Services was 14.5% for the period ended September 30, 2025, as compared to 15.2% and 14.6% for the periods ended June 30, 2025 and September 30, 2024, respectively. Total headcount as of September 30, 2025 was 349,800, an increase of 6,000 from June 30, 2025 and 9,700 from September 30, 2024.
Return of Capital to Shareholders
The Company repurchased 6.3 million shares for $450 million during the third quarter under its share repurchase program. Year-to-date, the company has repurchased 13.1 million shares for $994 million under the program. As of September 30, 2025, there was $2.2 billion remaining under the share repurchase authorization. In October 2025, the Company declared a quarterly cash dividend of $0.31 per share for shareholders of record on November 18, 2025. This dividend will be payable on November 26, 2025.
Fourth Quarter and Full-Year 2025 Guidance2
(all growth rates year-over-year)
|
____________________________ |
Select Company, Client and Partnership Announcements
Cognizant is building a portfolio of capabilities combined with deep domain expertise to harness and advance an AI-led future. Cognizant's progress has been accelerated through client agreements, platform enhancements, and partnerships. Recent announcements include:
Client Announcements
Platform Enhancements and Partnerships
Select Company Recognition, Announcements, and Analyst Ratings
Conference Call
Cognizant will host a conference call on October 29, 2025, at 8:30 a.m. (Eastern) to discuss the Company's third quarter 2025 results. To listen to the conference call, please dial (877) 810-9510 (domestic) or +1 (201) 493-6778 (international) and provide the following conference passcode: "Cognizant Call."
The conference call will also be available live on the Investor Relations section of the Cognizant website at http://investors.cognizant.com. An earnings supplement will also be available on the Cognizant website at the time of the conference call. For those who cannot access the live broadcast, a replay will be available. To listen to the replay, please dial (877) 660-6853 (domestically) or +1 (201) 612-7415 (internationally) and enter 13756237 beginning two hours after the end of the call until 11:59 p.m. (Eastern) on Wednesday, November 12, 2025. The replay will also be available at Cognizant's website www.cognizant.com for 60 days following the call.
About Cognizant
Cognizant (Nasdaq: CTSH) engineers modern businesses. We help our clients modernize technology, reimagine processes and transform experiences so they can stay ahead in our fast-changing world. Together, we're improving everyday life. See how at www.cognizant.com or @cognizant.
Forward-Looking Statements
This press release includes statements that may constitute forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the accuracy of which is necessarily subject to risks, uncertainties and assumptions as to future events that may not prove to be accurate. These statements include, but are not limited to, express or implied forward-looking statements relating to our strategy, strategic partnerships and collaborations, competitive position and opportunities in the marketplace, investment in and growth of our business, the pace and magnitude of change and client needs related to generative AI, effectiveness of our recruiting and talent efforts and related costs, labor market trends, the anticipated amount of capital to be returned to shareholders and our anticipated financial performance, matters related to the Belcan acquisition and other statements regarding matters that are not historical facts. These statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from those contemplated in these forward-looking statements. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Factors that could cause actual results to differ materially from those expressed or implied include general economic conditions, the competitive and rapidly changing nature of the markets we compete in, our ability to successfully use AI-based technologies and the impact those technologies may have on the demand and terms for our services, the competitive marketplace for talent and its impact on employee recruitment and retention, risks related to our NextGen program and the ultimate benefits of such program, legal, reputational and financial risks resulting from cyberattacks, changes in the regulatory environment, including with respect to immigration, trade and taxes, and the other factors discussed in our most recent Annual Report on Form 10-K and other filings with the Securities and Exchange Commission. Cognizant undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities law.
About Non-GAAP Financial Measures and Performance Metrics
Non-GAAP Financial Measures
To supplement our financial results presented in accordance with GAAP, this press release includes references to the following measures defined by the Securities and Exchange Commission as non-GAAP financial measures: Adjusted Operating Margin, Adjusted Net Income, Adjusted Diluted EPS (or Adjusted EPS), free cash flow, net cash and constant currency revenue growth. These non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles and should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and may be different from non-GAAP financial measures used by other companies. In addition, these non-GAAP financial measures should be read in conjunction with our financial statements prepared in accordance with GAAP. The reconciliations of our non-GAAP financial measures to the corresponding GAAP measures should be carefully evaluated.
Our non-GAAP financial measures Adjusted Operating Margin and Adjusted Income from Operations exclude unusual items, such as the gain on sale of property and equipment and NextGen charges. Our non-GAAP financial measures Adjusted Net Income and Adjusted Diluted EPS exclude unusual items, such as the one-time income tax expense related to the enactment of the OBBBA, the gain on sale of property and equipment and NextGen charges, net non-operating foreign currency exchange gains or losses and the tax impact of all the applicable adjustments. The income tax impact of each item excluded from Adjusted Net Income and Adjusted Diluted EPS is calculated by applying the statutory rate and local tax regulations in the jurisdiction in which the item was incurred. Free cash flow is defined as cash flows from operating activities plus proceeds from sale of property and equipment, net of purchases of property and equipment. Net cash is defined as cash and cash equivalents and short-term investments less short-term and long-term debt. Constant currency revenue growth is defined as revenues for a given period restated at the comparative period's foreign currency exchange rates measured against the comparative period's reported revenues.
Management believes providing investors with an operating view consistent with how we manage the Company provides enhanced transparency into our operating results. For our internal management reporting and budgeting purposes, we use various GAAP and non-GAAP financial measures for financial and operational decision-making, to evaluate period-to-period comparisons, to determine portions of the compensation for our executive officers and for making comparisons of our operating results to those of our competitors. Accordingly, we believe that the presentation of our non-GAAP measures, which exclude certain costs, when read in conjunction with our reported GAAP results, can provide useful supplemental information to our management and investors regarding financial and business trends relating to our financial condition and results of operations.
A limitation of using non-GAAP financial measures versus financial measures calculated in accordance with GAAP is that non-GAAP financial measures do not reflect all of the amounts associated with our operating results as determined in accordance with GAAP and may exclude costs that are recurring such as our net non-operating foreign currency exchange gains or losses. In addition, other companies may calculate non-GAAP financial measures differently than us, thereby limiting the usefulness of these non-GAAP financial measures as a comparative tool. We compensate for these limitations by providing specific information regarding the GAAP amounts excluded from our non-GAAP financial measures to allow investors to evaluate such non-GAAP financial measures.
Performance Metrics
Bookings are defined as total contract value (or TCV) of new contracts, including new contract sales as well as renewals and expansions of existing contracts. Bookings can vary significantly quarter to quarter depending in part on the timing of the signing of a small number of large contracts. Our book-to-bill ratio is defined as bookings for the trailing twelve months divided by revenue for the same period. Measuring bookings involves the use of estimates and judgments and there are no independent standards or requirements governing the calculation of bookings. The extent and timing of conversion of bookings to revenues may be impacted by, among other factors, the types of services and solutions sold, contract duration, the pace of client spending, actual volumes of services delivered as compared to the volumes anticipated at the time of sale, and contract modifications, including terminations, over the lifetime of a contract. The majority of our contracts are terminable by the client on short notice often without penalty, and some without notice. We do not update our bookings for subsequent terminations, reductions or foreign currency exchange rate fluctuations. Information regarding our bookings is not comparable to, nor should it be substituted for, an analysis of our reported revenues. However, management believes that it is a key indicator of potential future revenues and provides a useful indicator of the volume of our business over time. Large deals and mega deals are defined as deals with a total contract value of $100 million or greater and $500 million or greater, respectively.
|
Investor Relations Contact: |
|
|
|
Media Contact: |
|
Tyler Scott |
|
|
|
Jeff DeMarrais |
|
VP, Investor Relations |
|
|
|
SVP, Corporate Communications |
|
+1 551-220-8246 |
|
|
|
+1 475-223-2298 |
|
|
|
|
- tables to follow -
|
COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
|
|||||||
|
(in millions, except per share data) |
Three Months Ended
|
|
Nine Months Ended
|
||||
|
|
2025 |
|
2024 |
|
2025 |
|
2024 |
|
Revenues |
$ 5,415 |
|
$ 5,044 |
|
$ 15,775 |
|
$ 14,654 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
Cost of revenues (exclusive of depreciation and amortization expense shown separately below) |
3,581 |
|
3,311 |
|
10,457 |
|
9,661 |
|
Selling, general and administrative expenses |
833 |
|
833 |
|
2,434 |
|
2,379 |
|
Restructuring charges |
— |
|
33 |
|
— |
|
85 |
|
Depreciation and amortization expense |
135 |
|
129 |
|
410 |
|
388 |
|
(Gain) on sale of property and equipment |
— |
|
— |
|
(62) |
|
— |
|
Income from operations |
866 |
|
738 |
|
2,536 |
|
2,141 |
|
Other income (expense), net: |
|
|
|
|
|
|
|
|
Interest income |
25 |
|
31 |
|
78 |
|
91 |
|
Interest expense |
(8) |
|
(14) |
|
(29) |
|
(35) |
|
Foreign currency exchange gains (losses), net |
4 |
|
(8) |
|
13 |
|
(1) |
|
Other, net |
— |
|
1 |
|
3 |
|
2 |
|
Total other income (expense), net |
21 |
|
10 |
|
65 |
|
57 |
|
Income before provision for income taxes |
887 |
|
748 |
|
2,601 |
|
2,198 |
|
Provision for income taxes |
(613) |
|
(170) |
|
(1,023) |
|
(514) |
|
Income (loss) from equity method investment |
— |
|
4 |
|
4 |
|
10 |
|
Net income |
$ 274 |
|
$ 582 |
|
$ 1,582 |
|
$ 1,694 |
|
Basic earnings per share |
$ 0.56 |
|
$ 1.17 |
|
$ 3.22 |
|
$ 3.41 |
|
Diluted earnings per share |
$ 0.56 |
|
$ 1.17 |
|
$ 3.22 |
|
$ 3.41 |
|
Weighted average number of common shares outstanding - Basic |
486 |
|
496 |
|
491 |
|
497 |
|
Dilutive effect of shares issuable under stock-based compensation plans |
1 |
|
— |
|
— |
|
— |
|
Weighted average number of common shares outstanding - Diluted |
487 |
|
496 |
|
491 |
|
497 |
|
COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION CONSOLIDATED STATEMENTS OF FINANCIAL POSITION (Unaudited)
|
|||
|
(in millions, except par values) |
September 30,
|
|
December 31,
|
|
Assets |
|
|
|
|
Current assets: |
|
|
|
|
Cash and cash equivalents |
$ 2,341 |
|
$ 2,231 |
|
Short-term investments |
13 |
|
12 |
|
Trade accounts receivable, net |
4,391 |
|
4,059 |
|
Other current assets |
1,349 |
|
1,202 |
|
Total current assets |
8,094 |
|
7,504 |
|
Property and equipment, net |
949 |
|
994 |
|
Operating lease assets, net |
578 |
|
552 |
|
Goodwill |
7,100 |
|
6,953 |
|
Intangible assets, net |
1,472 |
|
1,599 |
|
Deferred income tax assets, net |
844 |
|
1,248 |
|
Long-term investments |
107 |
|
90 |
|
Other noncurrent assets |
990 |
|
1,026 |
|
Total assets |
$ 20,134 |
|
$ 19,966 |
|
Liabilities and Stockholders' Equity |
|
|
|
|
Current liabilities: |
|
|
|
|
Accounts payable |
$ 284 |
|
$ 340 |
|
Deferred revenue |
384 |
|
450 |
|
Short-term debt |
33 |
|
33 |
|
Operating lease liabilities |
154 |
|
152 |
|
Accrued expenses and other current liabilities |
2,578 |
|
2,610 |
|
Total current liabilities |
3,433 |
|
3,585 |
|
Deferred revenue, noncurrent |
35 |
|
30 |
|
Operating lease liabilities, noncurrent |
432 |
|
420 |
|
Deferred income tax liabilities, net |
168 |
|
154 |
|
Long-term debt |
551 |
|
875 |
|
Other noncurrent liabilities |
618 |
|
494 |
|
Total liabilities |
5,237 |
|
5,558 |
|
Stockholders' equity: |
|
|
|
|
Preferred stock, $0.10 par value, 15 shares authorized, none issued |
— |
|
— |
|
Class A common stock, $0.01 par value, 1,000 shares authorized, 483 and 495 shares issued |
5 |
|
5 |
|
Additional paid-in capital |
14 |
|
13 |
|
Retained earnings |
14,942 |
|
14,686 |
|
Accumulated other comprehensive income (loss) |
(64) |
|
(296) |
|
Total stockholders' equity |
14,897 |
|
14,408 |
|
Total liabilities and stockholders' equity |
$ 20,134 |
|
$ 19,966 |
|
COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION Reconciliations of Non-GAAP Financial Measures (Unaudited)
|
|||||||||
|
(dollars in millions, except per share amounts) |
Three Months Ended
|
|
Nine Months Ended
|
|
Guidance |
||||
|
|
2025 |
|
2024 |
|
2025 |
|
2024 |
|
Full Year 2025 (1) |
|
GAAP income from operations |
$ 866 |
|
$ 738 |
|
$ 2,536 |
|
$ 2,141 |
|
|
|
(Gain) on sale of property and equipment(a) |
— |
|
— |
|
(62) |
|
— |
|
|
|
NextGen charges(b) |
— |
|
33 |
|
— |
|
85 |
|
|
|
Adjusted Income From Operations |
$ 866 |
|
$ 771 |
|
$ 2,474 |
|
$ 2,226 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP operating margin |
16.0 % |
|
14.6 % |
|
16.1 % |
|
14.6 % |
|
|
|
(Gain) on sale of property and equipment |
— |
|
— |
|
(0.4) |
|
— |
|
(0.3) % |
|
NextGen charges |
— |
|
0.7 |
|
— |
|
0.6 |
|
— |
|
Adjusted Operating Margin |
16.0 % |
|
15.3 % |
|
15.7 % |
|
15.2 % |
|
~15.7% |
|
|
|
|
|
|
|
|
|
|
|
|
GAAP net income |
$ 274 |
|
$ 582 |
|
$ 1,582 |
|
$ 1,694 |
|
|
|
Effect of adjustments to income from operations, pre-tax |
— |
|
33 |
|
(62) |
|
85 |
|
|
|
Non-operating foreign currency exchange (gains) losses, pre-tax(c) |
(4) |
|
8 |
|
(13) |
|
1 |
|
|
|
Tax effect of above adjustments(d) |
15 |
|
(5) |
|
34 |
|
(18) |
|
|
|
One-time income tax expense related to the enactment of the OBBBA(e) |
390 |
|
— |
|
390 |
|
— |
|
|
|
Adjusted Net Income |
$ 675 |
|
$ 618 |
|
$ 1,931 |
|
$ 1,762 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP diluted earnings per share |
$ 0.56 |
|
$ 1.17 |
|
$ 3.22 |
|
$ 3.41 |
|
|
|
Effect of adjustments to income from operations, pre-tax |
— |
|
0.07 |
|
(0.13) |
|
0.17 |
|
$(0.13) |
|
Non-operating foreign currency exchange (gains) losses, pre-tax(c) |
(0.01) |
|
0.02 |
|
(0.03) |
|
— |
|
(c) |
|
Tax effect of above adjustments(d) |
0.04 |
|
(0.01) |
|
0.08 |
|
(0.03) |
|
(a) (c) |
|
One-time income tax expense related to the enactment of the OBBBA(e) |
0.80 |
|
— |
|
0.79 |
|
— |
|
0.80 |
|
Adjusted Diluted Earnings Per Share |
$ 1.39 |
|
$ 1.25 |
|
$ 3.93 |
|
$ 3.55 |
|
$5.22 - $5.26 |
|
(1) |
A full reconciliation of Adjusted Operating Margin and Adjusted Diluted Earnings Per Share guidance to the corresponding GAAP measures on a forward-looking basis cannot be provided without unreasonable efforts, as we are unable to provide reconciling information with respect to unusual items, net non-operating foreign currency exchange gains or losses and the tax effects of these adjustments, and such adjustments may be significant. |
|
Notes: |
|
|
(a) |
During the three months ended March 31, 2025, we realized a gain on the sale of an office complex in India, which was reported in "(Gain) on sale of property and equipment" on our unaudited consolidated statement of operations. Our guidance anticipates pre-tax charges of approximately $(0.13) per diluted share for the full year 2025. The tax effect of these charges is expected to be approximately $0.02 per diluted share for the full year 2025. |
|
(b) |
NextGen charges for the three months ended September 30, 2024 include $29 million of employee separation costs and $4 million of facility exit costs. NextGen charges for the nine months ended September 30, 2024 include $55 million of employee separation costs, $29 million of facility exit costs and $1 million of third party and other costs. The program concluded on December 31, 2024. The costs related to the NextGen program are reported in "Restructuring charges" in our unaudited consolidated statements of operations. |
|
(c) |
Non-operating foreign currency exchange gains and losses, inclusive of gains and losses on related foreign exchange forward contracts not designated as hedging instruments for accounting purposes, are reported in "Foreign currency exchange gains (losses), net" in our unaudited consolidated statements of operations. Non-operating foreign currency exchange gains and losses are subject to high variability and low visibility and therefore cannot be provided on a forward-looking basis without unreasonable efforts. |
|
(d) |
Presented below are the tax impacts of our non-GAAP adjustment to pre-tax income for the: |
|
(in millions) |
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
||||
|
|
2025 |
|
2024 |
|
2025 |
|
2024 |
|
Non-GAAP income tax benefit (expense) related to: |
|
|
|
|
|
|
|
|
Gain on sale of property and equipment |
$ — |
|
$ — |
|
$ (9) |
|
$ — |
|
NextGen charges |
— |
|
8 |
|
— |
|
21 |
|
Foreign currency exchange gains and losses |
(15) |
|
(3) |
|
(25) |
|
(3) |
|
|
The effective tax rate related to non-operating foreign currency exchange gains and losses varies depending on the jurisdictions in which such income and expenses are generated and the statutory rates applicable in those jurisdictions. As such, the income tax effect of non-operating foreign currency exchange gains and losses shown in the above table may not appear proportionate to the net pre-tax foreign currency exchange gains and losses reported in our unaudited consolidated statements of operations. |
|
(e) |
In July 2025, the One Big Beautiful Bill Act ("OBBBA") was enacted in the United States, which, among other provisions, repealed the requirement to capitalize U.S. research and experimental ("R&E") costs. As a result, we do not believe it is more likely than not that we will realize our deferred tax asset of $390 million related to R&E costs capitalized outside the United States. These amounts would have otherwise been available to offset certain future U.S. taxes on our non-U.S. earnings, which, as a result of this repeal, we no longer project to be applicable to us. Therefore, in the third quarter of 2025, we recorded a one-time, non-cash income tax expense of $390 million. |
|
Reconciliations of Net Cash (Unaudited)
|
||||
|
(in millions) |
|
September 30, 2025 |
|
December 31, 2024 |
|
Cash and unrestricted cash equivalents |
|
$ 2,341 |
|
$ 2,231 |
|
Short-term investments |
|
13 |
|
12 |
|
Less: |
|
|
|
|
|
Short-term debt |
|
33 |
|
33 |
|
Long-term debt |
|
551 |
|
875 |
|
Net cash |
|
$ 1,770 |
|
$ 1,335 |
|
The above tables serve to reconcile the Non-GAAP financial measures to the most directly comparable GAAP measures. Refer to the "About Non-GAAP Financial Measures and Performance Metrics" section of our press release for further information on the use of these Non-GAAP measures. |
|
COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION Revenue by Business Segment and Geography (Unaudited)
|
|||||||
|
(dollars in millions) |
Three Months Ended September 30, 2025 |
||||||
|
|
|
|
|
|
Year over Year |
||
|
|
$ |
|
% of total |
|
% Change |
|
Constant Currency |
|
Revenues by Segment: |
|
|
|
|
|
|
|
|
Health Sciences |
$ 1,604 |
|
29.6 % |
|
5.9 % |
|
5.1 % |
|
Financial Services |
1,578 |
|
29.2 % |
|
6.2 % |
|
5.4 % |
|
Products and Resources(b) |
1,383 |
|
25.5 % |
|
12.6 % |
|
11.4 % |
|
Communications, Media and Technology |
850 |
|
15.7 % |
|
4.2 % |
|
3.6 % |
|
Total Revenues(b) |
$ 5,415 |
|
|
|
7.4 % |
|
6.5 % |
|
Revenues by Geography: |
|
|
|
|
|
|
|
|
North America(b) |
$ 4,028 |
|
74.4 % |
|
7.8 % |
|
7.8 % |
|
United Kingdom |
503 |
|
9.2 % |
|
4.4 % |
|
0.7 % |
|
Continental Europe |
539 |
|
10.0 % |
|
11.1 % |
|
4.6 % |
|
Europe - Total |
1,042 |
|
19.2 % |
|
7.8 % |
|
2.7 % |
|
Rest of World |
345 |
|
6.4 % |
|
0.9 % |
|
2.6 % |
|
Total Revenues(b) |
$ 5,415 |
|
|
|
7.4 % |
|
6.5 % |
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30, 2025 |
||||||
|
|
|
|
|
|
Year over Year |
||
|
|
$ |
|
% of total |
|
% Change |
|
Constant Currency |
|
Revenues by Segment: |
|
|
|
|
|
|
|
|
Health Sciences |
$ 4,726 |
|
30.0 % |
|
7.6 % |
|
7.2 % |
|
Financial Services |
4,587 |
|
29.1 % |
|
6.2 % |
|
5.9 % |
|
Products and Resources(b) |
3,967 |
|
25.1 % |
|
13.8 % |
|
13.2 % |
|
Communications, Media and Technology |
2,495 |
|
15.8 % |
|
1.5 % |
|
1.3 % |
|
Total Revenues(b) |
$ 15,775 |
|
|
|
7.6 % |
|
7.3 % |
|
Revenues by Geography: |
|
|
|
|
|
|
|
|
North America(b) |
$ 11,794 |
|
74.8 % |
|
8.4 % |
|
8.5 % |
|
United Kingdom |
1,442 |
|
9.1 % |
|
4.3 % |
|
1.6 % |
|
Continental Europe |
1,552 |
|
9.8 % |
|
7.9 % |
|
4.8 % |
|
Europe - Total |
2,994 |
|
18.9 % |
|
6.2 % |
|
3.2 % |
|
Rest of World |
987 |
|
6.3 % |
|
3.0 % |
|
5.1 % |
|
Total Revenues(b) |
$ 15,775 |
|
|
|
7.6 % |
|
7.3 % |
|
Notes: |
|
|
(a) |
Constant currency revenue growth is not a measure of financial performance prepared in accordance with GAAP. See "About Non-GAAP Financial Measures and Performance Metrics" section of our press release for further information. |
|
(b) |
For the three and nine months ended September 30, 2025, our acquisition of Belcan contributed approximately 250 basis points and approximately 350 basis points to overall revenue growth, respectively, primarily in North America and to a lesser extent in the United Kingdom. Additionally, Belcan contributed approximately 900 and 1,300 basis points of growth to our Products and Resources segment for the three and nine months ended September 30, 2025, respectively. |
|
COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
|
|||||||
|
(in millions) |
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
||||
|
|
2025 |
|
2024 |
|
2025 |
|
2024 |
|
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
Net income |
$ 274 |
|
$ 582 |
|
$ 1,582 |
|
$ 1,694 |
|
Adjustments for non-cash income and expenses |
600 |
|
92 |
|
897 |
|
354 |
|
Changes in operating assets and liabilities, net of effects of businesses acquired |
353 |
|
173 |
|
(454) |
|
(844) |
|
Net cash provided by operating activities |
1,227 |
|
847 |
|
2,025 |
|
1,204 |
|
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
Purchases of property and equipment |
(67) |
|
(56) |
|
(211) |
|
(214) |
|
Proceeds from sale of property and equipment |
— |
|
— |
|
70 |
|
— |
|
Net maturities (purchases) of investments |
1 |
|
— |
|
(14) |
|
262 |
|
Payments for business combinations, net of cash acquired |
— |
|
(1,194) |
|
— |
|
(1,615) |
|
Net cash (used in) investing activities |
(66) |
|
(1,250) |
|
(155) |
|
(1,567) |
|
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
Issuance of common stock under stock-based compensation plans |
13 |
|
14 |
|
46 |
|
49 |
|
Repurchases of common stock |
(463) |
|
(242) |
|
(1,040) |
|
(451) |
|
Net change in term loan borrowings and earnout obligations and finance leases |
(11) |
|
(11) |
|
(32) |
|
(61) |
|
Proceeds from borrowing under the revolving credit facility |
— |
|
600 |
|
— |
|
600 |
|
Repayment of notes outstanding under the revolving credit facility |
— |
|
— |
|
(300) |
|
— |
|
Dividends paid |
(151) |
|
(149) |
|
(459) |
|
(450) |
|
Net cash (used in) provided by financing activities |
(612) |
|
212 |
|
(1,785) |
|
(313) |
|
Effect of exchange rate changes on cash, cash equivalents and restricted cash and cash equivalents |
(4) |
|
11 |
|
25 |
|
(28) |
|
Increase (decrease) in cash, cash equivalents and restricted cash and cash equivalents |
545 |
|
(180) |
|
110 |
|
(704) |
|
Cash, cash equivalents and restricted cash and cash equivalents, beginning of period |
1,796 |
|
2,193 |
|
2,231 |
|
2,717 |
|
Cash and cash equivalents, end of period |
$ 2,341 |
|
$ 2,013 |
|
$ 2,341 |
|
$ 2,013 |
|
SUPPLEMENTAL CASH FLOW INFORMATION |
|||
|
(in millions) |
Three Months Ended September 30, |
||
|
Stock Repurchases under Board of Directors' authorized stock repurchase program: |
2025 |
|
2024 |
|
Number of shares repurchased |
6.3 |
|
3.1 |
|
|
|
|
|
|
Remaining authorized balance as of September 30, 2025 |
$ 2,243 |
|
|
|
Reconciliation of Free Cash Flow Non-GAAP Financial Measure
|
|||||||
|
(in millions) |
Three Months Ended September 30, |
|
Nine Months Ended September 30, |
||||
|
|
2025 |
|
2024 |
|
2025 |
|
2024 |
|
Net cash provided by operating activities |
$ 1,227 |
|
$ 847 |
|
$ 2,025 |
|
$ 1,204 |
|
Purchases of property and equipment |
(67) |
|
(56) |
|
(211) |
|
(214) |
|
Proceeds from sale of property and equipment |
— |
|
— |
|
70 |
|
— |
|
Free cash flow |
$ 1,160 |
|
$ 791 |
|
$ 1,884 |
|
$ 990 |
SOURCE Cognizant Technology Solutions Corporation
| 1 hour | |
| 1 hour | |
| 2 hours | |
| 3 hours | |
| Oct-28 | |
| Oct-28 | |
| Oct-27 | |
| Oct-27 | |
| Oct-27 | |
| Oct-27 | |
| Oct-24 | |
| Oct-24 | |
| Oct-24 | |
| Oct-24 | |
| Oct-24 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
